Global Medical REIT (NYSE:GMRE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “Global Medical REIT Inc. is engaged primarily in the acquisition of licensed, state-of-the-art, purpose-built healthcare facilities and the leasing of these facilities to clinical operators. Global Medical REIT Inc. is based in Denver, United States. “

Separately, B. Riley reaffirmed a “buy” rating on shares of Global Medical REIT in a research report on Wednesday, November 1st. Two investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. Global Medical REIT currently has an average rating of “Buy” and an average price target of $10.50.

Shares of Global Medical REIT (NYSE:GMRE) opened at $8.09 on Wednesday. The company has a current ratio of 0.22, a quick ratio of 0.22 and a debt-to-equity ratio of 0.72. Global Medical REIT has a 1 year low of $7.85 and a 1 year high of $10.25. The stock has a market cap of $174.99, a price-to-earnings ratio of -40.45, a price-to-earnings-growth ratio of 1.33 and a beta of -48.24.

Global Medical REIT (NYSE:GMRE) last posted its quarterly earnings results on Thursday, November 9th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.12 by ($0.10). Global Medical REIT had a negative return on equity of 2.86% and a negative net margin of 19.98%. equities analysts anticipate that Global Medical REIT will post 0.33 EPS for the current fiscal year.

Several large investors have recently added to or reduced their stakes in GMRE. SG Americas Securities LLC acquired a new position in shares of Global Medical REIT in the third quarter valued at $115,000. Nomura Asset Management Co. Ltd. acquired a new position in shares of Global Medical REIT in the third quarter valued at $120,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in shares of Global Medical REIT in the third quarter valued at $154,000. Rhumbline Advisers increased its holdings in shares of Global Medical REIT by 47.6% in the second quarter. Rhumbline Advisers now owns 17,699 shares of the company’s stock valued at $158,000 after purchasing an additional 5,710 shares during the last quarter. Finally, Raymond James Financial Services Advisors Inc. acquired a new position in shares of Global Medical REIT in the second quarter valued at $185,000. Hedge funds and other institutional investors own 41.02% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was published by Watch List News and is the property of of Watch List News. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at https://www.watchlistnews.com/global-medical-reit-gmre-downgraded-by-zacks-investment-research/1809952.html.

Global Medical REIT Company Profile

Get a free copy of the Zacks research report on Global Medical REIT (GMRE)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.